Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)

NCT06469307 is registered in ClinicalTrials.gov with Dana-Farber Cancer Institute as lead sponsor.

NCT NCT06469307
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06469307 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Driving Inclusivity, Validity, and Equity in Research Through Strategic Engagement (DIVERSE)
Lead sponsor
Dana-Farber Cancer Institute
Phase
Not applicable
Overall status
Recruiting
Start date
December 9, 2024
Completion date
January 30, 2028
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood cancer, leukemia